Does rat global transient cerebral ischemia serve as an appropriate model to study emotional disturbances?

Fundamental and Clinical Pharmacology

Volumn 18, Issue 6, 2004, Pages 685-692

  Bantsiele, Guy Bernard ^a   Bentué Ferrer, Danièle ^a   Amiot, Noëlla ^a   Allain, Hervé ^a   Bourin, Michel ^b   Reymann, Jean Michel ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

^b UNIVERSITÉ DE NANTES   (France)

Author keywords

Elevated plus maze; Forced swimming test; Global ischemia; Poststroke depression; Psychotropics

Indexed keywords

DIAZEPAM; IMIPRAMINE; PSYCHOTROPIC AGENT; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; DEPRESSION; EMOTIONAL DISORDER; FORCED SWIMMING TEST; MALE; MAZE TEST; MOOD DISORDER; MOTOR ACTIVITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RAT; STROKE; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANXIETY; DEPRESSION; DIAZEPAM; DISEASE MODELS, ANIMAL; IMIPRAMINE; ISCHEMIC ATTACK, TRANSIENT; MALE; MAZE LEARNING; MOTOR ACTIVITY; RATS; RATS, WISTAR; SWIMMING;

EID: 9444258077     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2004.00295.x     Document Type: Article

References (44)

1. Pohjasvaara T., Leppävuori A., Siira I., Vataja R., Kaste M., Erkinjuntti T. Frequency and clinical determinants of poststroke depression. Stroke (1998) 29 2311-2317.
2. Whyte E.M., Mulsant B.H. Post stroke depression: epidemiology, pathophysiology, and biological treatment. Biol. Psychiatry (2002) 52 253-264.
3. Ghoge H., Sharma S., Sonawalla S., Parikh R. Cerebrovascular diseases and depression. Curr. Psychiatry Rep. (2003) 5 231-238.
4. Robinson N.K. Stroke related depression. Curr. Atheroscler. Rep. (2002) 4 296-303.
5. Kotila M., Numminen H., Waltimo O., Kaste M. Depression after stroke: results of the FINNSTROKE study. Stroke (1998) 2 368-372.
6. Kimura M., Tateno A., Robinson R.G. Treatment of post-stroke generalized anxiety disorder comorbid with poststroke depression: merged analysis of nortriptyline trials. Am. J. Geriatr. Psychiatry (2003) 11 320-327.
7. Leppävuori A., Pohjasvaara T., Vataja R., Kaste M., Erkinjuntti T. Generalized anxiety disorders three to four months after ischemic stroke. Cerebrovasc. Dis. (2003) 16 257-264.
8. Alexopoulos G.S., Meyers B.S., Young R.C., Kakuma T., Silbersweig D., Charlson M. Clinically defined vascular depression. Am. J. Psychiatry (1997) 154 562-565.
9. Rasmussen A., Lunde M., Poulsen D.L., Sorensen K., Qvitzau S., Bech P. A double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke patients. Psychosomatics (2003) 44 216-221.
10. Allain H., Schuck S., Mauduit N. Depression in Parkinson's disease. BMJ (2000) 320 1287-1288.
11. Allain H., Schück S., Bentué-Ferrer D. et al. Anxiolytics in the treatment of behavioral and psychological symptoms of dementia. Int. Psychogeriatr. (2000) 12 (Suppl. 1) 281-289.
12. Hossmann K.A. Experimental models for the investigation of brain ischemia. Cardiovasc. Res. (1998) 39 106-120.
13. O'Neill M., Allain H., Bentué-Ferrer D., Bellissant E., de Certaines J., Leonard B.E. Pharmacological strategies in the treatment of cerebral ischemia. Eur. Neurol. (1995) 35 (Suppl. 1) 28-36.
14. Caldwell M., Reymann J.M., Allain H., Leonard B.E., Bentué-Ferrer D. Lisuride prevents learning and memory impairment and attenuates the increase in extracellular dopamine induced by transient global cerebral ischemia. Brain Res. (1997) 771 305-318.
15. Lucki I. The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav. Pharmacol. (1997) 8 523-532.
16. Handley S.L., McBlane J.W. An assessment of the elevated X-maze for studying anxiety and anxiety-modulating drugs. J. Pharmacol. Toxicol. Methods (1993) 29 129-138.
17. Pellow S., Chopin P., File S.E., Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods (1985) 14 149-167.
18. Rodgers R.J., Cole J.C. The elevated plus-maze: pharmacology, methodology and ethology, in: Cooper S.J., Hendrie C.A. (Eds). Ethology and psychopharmacology, John Wiley & Sons Ltd., Chichester (1994) 5-44.
19. Chauhan N., Zhao Z., Barber P.A., Buchan A.M. Lessons in experimental ischemia for clinical stroke medicine. Curr. Opin. Neurol. (2003) 16 65-71.
20. Volpe B.T., Pulsinelli W.A., Tribuna J., Davis H.P. Behavioral performance of rats following transient forebrain ischemia. Stroke (1984) 15 558-562.
21. Briones T.L., Therrien B. Behavioral effects of transient cerebral ischemia. Biol. Res. Nurs. (2000) 1 276-286.
22. Pulsinelli W.A., Brierly J.B. A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke (1979) 10 267-271.
23. Capdeville C., Plokine M., Boulu R.G. Méthodes d'appréciation du déficit neurologique induit par une ischémie cérébrale transitoire chez le rat éveillé. J. Pharmacol. (Paris) (1984) 15 231-237.
24. Porsolt R.D., Anton G., Blavet N., Jalfre M. Behavioral despair in rats: a new model sensitive to antidepressant treatments. Eur. J. Pharmacol. (1978) 7 379-391.
25. Poignet H., Beaughard M., Lecoin G., Massingham R. Functional, behavioral, and histological changes induced by transient global cerebral ischemia in rats: effects of cinnarizine and flunarizine. J. Cereb. Blood Flow Metab. (1989) 9 646-654.
26. Block F., Schwarz M. Dextromethorphan reduces functional deficits and neuronal damage after global ischemia in rats. Brain Res. (1996) 741 153-159.
27. Puurunen K., Sirvio J., Koistinaho J. et al. Studies on the influence of enriched-environment housing combined with systemic administration of an alpha2-adrenergic antagonist on spatial learning and hyperactivity after global ischemia in rats. Stroke (1997) 28 623-631.
28. Kuroiwa T., Bonnekoh P., Hossmann K.A. Locomotor hyperactivity and hippocampal CA1 injury after transient forebrain ischemia of gerbils. Neurosci. Lett. (1991) 122 141-144.
29. Mileson B.E., Schwartz R.D. The use of locomotor activity as a behavioral screen for neuronal damage following transient forebrain ischemia in gerbils. Neurosci. Lett. (1991) 128 71-76.
30. Katsuta K., Umemura K., Ueyama N., Matsuoka N. Pharmacological evidence for a correlation between hippocampal CA1 cell damage and hyperlocomotion following global cerebral ischemia in gerbils. Bur. J. Pharmacol. (2003) 467 103-109.
31. Araki H., Hino N., Karasawa Y., Kawasaki H., Gomita Y. Effect of dopamine blockers on cerebral ischemia-induced hyperactivity in gerbils. Physiol. Behav. (1999) 66 263-268.
32. Araki H., Yamamoto T., Kobayashi Y., Futagami K., Kawasaki H., Gomita Y. Effect of methamphetamine and imipramine on cerebral ischemia-induced hyperactivity in Mongolian gerbils. Jpn. J. Pharmacol. (2002) 88 293-299.
33. Yamamoto T., Araki H., Futagami K., Kawasaki H., Gomita Y. Dopaminergic neurotransmission triggers ischemia-induced hyperactivity in Mongolian gerbils. Acta Med. Okayama (2001) 55 277-282.
34. Seligman ME. Beagley G. Learned helplessness in the rat. J. Comp. Physiol. Psychol. (1975) 88 534-541.
35. Yan B., Wang D.Y., Xing D.M. et al. The antidepressant effect of ethanol extract of radix puerariae in mice exposed to cerebral ischemia reperfusion. Pharmacol. Biochem. Behav. (2004) 78 319-325.
36. Kato M., Iwata H., Katayama T., Asai H., Narita H., Endo T. Possible therapeutic effect of T-794, a novel reversible inhibitor of monoamine oxidase-A, on post-stroke emotional disturbances, assessed in animal models of depression. Biol. Pharm. Bull. (1997) 20 349-353.
37. Kato M., Iwata H., Okamoto M., Ishii, T., Narita H. Focal cerebral ischemia-induced escape deficit in rats is ameliorated by a reversible inhibitor of monoamine oxidase-A: implications for a novel animal model of post-stroke depression. Biol. Pharm. Bull. (2000) 23 406-410.
38. Dhooper A., Young C., Reid K.H. Ischemia induced anxiety following cardiac arrest in the rat. Behav. Brain Res. (1996) 84 57-62.
39. Bourin M., Fiocco A.J., Clenet F. How valuable are animal models in defining antidepressant activity? Hum. Psychopharmacol. (2001) 16 9-21.
40. Cryan J.F., Markou A., Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol. Sci. (2002) 23 238-246.
41. Carson A., MacHale S., Allen K. et al. Depression after stroke and lesion location: a systematic review. Lancet (2000) 356 122-126.
42. Le Doux J.E. Emotional memory systems in the brain. Behav. Brain Res. (1993) 58 69-79.
43. Mongeau R., Blier P., de Montigny C. The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments. Brain Res. Rev. (1997) 23 145-195.
44. Santarelli L., Saxe M., Gross C. et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science (2003) 301 805-809.